ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
의료용 동위원소 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년에는 연평균 7.8%의 CAGR로 99억 2,000만 달러에 달할 것으로 예상됩니다. 예측 기간 동안의 성장은 공중 보건에 대한 노력, 파트너십 및 협업, 인프라 투자, 맞춤형 의료로의 전환, 노인 인구 증가, 규제 변화, 표준화 등에 기인하는 것으로 보입니다. 예측 기간 동안 주요 동향으로는 방사성의약품의 성장, 사이클로트론 및 제너레이터 기술 채택, 공급망 강건성 강화, 인공지능(AI) 통합, 양전자방사선단층촬영(PET) 이미징의 발전 등을 들 수 있습니다.
암과 심장 질환의 발생률 증가는 향후 몇 년 동안 의료용 동위원소 시장의 성장을 촉진할 것으로 예상됩니다. 이러한 질병 발생률은 특정 기간 동안 인구 집단 내 신규 발병 빈도 및 유병률을 의미하며, 공중 보건 동향 및 예방 조치의 효과에 대한 인사이트를 제공합니다. 암과 심장병의 유병률 증가는 현대 기술 및 사무직 중심의 직업으로 인한 좌식 생활습관의 확산과 관련이 있으며, 이로 인해 신체활동 수준이 감소하고 있습니다. 암과 심장병의 진단과 치료에는 양전자방사선단층촬영(PET), 단일광자방사선단층촬영(SPECT)과 같은 영상 진단기술과 방사선 치료, 방사성 스텐트 등의 치료법이 필수적입니다. 예를 들어, 스위스에 본부를 둔 정부 간 기구인 세계보건기구(WHO)에 따르면, 2050년까지 새로 발생하는 암 환자 수는 3,500만 명을 넘어설 것으로 예측되며, 이는 2022년 추정 환자 수 2,000만 명에 비해 77% 증가한 수치입니다. 또한, 영국에 기반을 둔 심혈관 연구 자선단체인 영국 심장 재단의 데이터에 따르면, 2024년 9월 현재 영국에서 약 760만 명이 심장 및 순환기 질환을 앓고 있으며, 이 중 약 400만 명은 남성, 360만 명은 여성으로 추정됩니다. 이들 질환은 영국 전체 사망자의 약 27%를 차지하며, 연간 17만 명 이상, 하루에 약 480명, 3분마다 1명씩 사망하고 있습니다. 이처럼 암과 심장병의 발병률 증가는 의료용 동위원소 시장의 성장에 박차를 가하고 있습니다.
의료용 동위원소 시장의 주요 기업들은 경쟁력을 강화하기 위해 전략적 제휴에 주력하고 있습니다. 전략적 제휴는 두 개 이상의 당사자가 특정 상호 이익이 되는 목적을 공동으로 추구하기 위한 공식적인 합의입니다. 예를 들어, 2023년 9월 미국 의료 기술 기업 인터내셔널 아이소토프스(International Isotopes)는 미국 바이오메디컬 하드웨어 기업 팬텍 메디컬(Phantech Medical)과 제휴를 맺고 양사의 고객 솔루션을 통합했습니다. 이번 제휴는 의료 영상 및 세라믹스 분야에 맞는 혁신적인 밀폐형 선원을 개발, 제조 및 판매함으로써 전임상 영상용 교정 및 참조선원 시장을 변화시키는 것을 목표로 하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 신종 코로나바이러스 감염증, 그리고 경기회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계 의료용 동위원소 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업 분석
세계의 의료용 동위원소 시장 : 성장률 분석
세계의 의료용 동위원소 시장 실적 : 규모와 성장, 2019-2024
세계의 의료용 동위원소 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계 의료용 동위원소 전체 시장(TAM)
제6장 시장 세분화
세계의 의료용 동위원소 시장 : 제품 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
안정동위원소
방사성동위원소
세계의 의료용 동위원소 시장 : 제조 방법별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
중성자 방사화
사이클로트론
원자로
기타 제조 방법
세계의 의료용 동위원소 시장 : 용도별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
핵의학 치료
기기 방사성원
진단
세계의 의료용 동위원소 시장 : 최종 용도별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
병원
진단 센터
조사기관
세계의 의료용 동위원소 시장, 안정동위원소 하위 세분화(종류별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
탄소 13
질소 15
산소 18
기타 안정동위원소
세계의 의료용 동위원소 시장, 방사성동위원소 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
테크네튬 99m
요오드 131
코발트 60
스트론튬 89
기타 방사성동위원소
제7장 지역별·국가별 분석
세계의 의료용 동위원소 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 의료용 동위원소 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
의료용 동위원소 시장 : 경쟁 구도
의료용 동위원소 시장 : 기업 개요
Rosatom State Atomic Energy Corporation Overview, Products and Services, Strategy and Financial Analysis
Bayer AG Overview, Products and Services, Strategy and Financial Analysis
Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
GE HealthCare Overview, Products and Services, Strategy and Financial Analysis
Urenco Ltd. Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
Lantheus Holdings Inc.
Curium Pharma
Canadian Nuclear Laboratories
Eckert & Ziegler Strahlen-und Medizintechnik AG.
Advanced Accelerator Applications a Novartis company
Nordion Inc.
NTP Radioisotopes SOC Ltd.
The Institute for Radioelements(IRE)
NorthStar Medical Radioisotopes LLC
Isotopen Technologien Munchen AG(ITM)
EczacIbasI-Monrol Nuclear Products Co.
SHINE Medical Technologies LLC
Blue Earth Diagnostics Limited
Isologic Innovative Radiopharmaceuticals
IBA Radiopharma Solutions
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
의료용 동위원소 시장 2029 : 새로운 기회를 제공하는 국가
의료용 동위원소 시장 2029 : 새로운 기회를 제공하는 부문
의료용 동위원소 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁 전략
제36장 부록
ksm
영문 목차
영문목차
Medical isotopes are radioisotopes utilized in medicine, emitting positrons or gamma rays for diagnostic purposes. These isotopes aid in visualizing and targeting specific tissues or abnormalities within the body, facilitating tasks such as evaluating heart function, assessing blood flow to the heart muscle, and diagnosing coronary artery disease.
The main product types of medical isotopes comprise stable isotopes and radioisotopes. Stable isotopes are versions of chemical elements that do not decay over time, retaining their atomic structure indefinitely. Production methods for medical isotopes include neutron activation, cyclotrons, nuclear reactors, and others. These isotopes find applications in nuclear therapy, equipment radioactive sources, and diagnostic procedures. End users of medical isotopes include hospitals, diagnostic centers, and research institutes.
The medical isotopes market research report is one of a series of new reports from The Business Research Company that provides medical isotopes market statistics, including the medical isotopes industry global market size, regional shares, competitors with the medical isotopes market share, detailed medical isotopes market segments, market trends, and opportunities, and any further data you may need to thrive in the medical isotopes industry. These medical isotopes market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The medical isotopes market size has grown strongly in recent years. It will grow from $6.8 billion in 2024 to $7.35 billion in 2025 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to the rising incidence of chronic diseases, expansion of the pharmaceutical industry, advancements in cancer treatment, demand for diagnostic imaging, and advancements in nuclear medicine.
The medical isotopes market size is expected to see strong growth in the next few years. It will grow to $9.92 billion in 2029 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to public health initiatives, partnerships and collaborations, investment in infrastructure, a shift towards personalized medicine, a growing geriatric population, regulatory changes, and standards. Major trends in the forecast period include growth in radiopharmaceuticals, adoption of cyclotron and generator technologies, focus on supply chain resilience, integration of artificial intelligence (AI), and advancements in positron emission tomography (PET) imaging.
The increasing rates of cancer and heart disease are expected to drive the growth of the medical isotope market in the coming years. These rates refer to the frequency of new cases and the prevalence of these diseases within a population over a specific period, offering insights into public health trends and the effectiveness of preventive measures. The growing prevalence of cancer and heart disease is linked to the widespread sedentary lifestyle promoted by modern technology and desk-based occupations, which result in lower physical activity levels. Medical isotopes are crucial in diagnosing and treating cancer and heart disease, utilizing imaging techniques such as positron emission tomography (PET) and single photon emission computed tomography (SPECT) scans, as well as therapies like radiation therapy and radioactive stents. For instance, according to the World Health Organization (WHO), a Switzerland-based intergovernmental organization, by 2050, the number of new cancer cases is projected to exceed 35 million, representing a 77% increase compared to the estimated 20 million cases in 2022. Additionally, data from the British Heart Foundation, a UK-based cardiovascular research charity, indicated that as of September 2024, approximately 7.6 million people in the UK are affected by heart and circulatory diseases, with around 4 million men and 3.6 million women living with these conditions. These diseases account for about 27% of all deaths in the UK, resulting in over 170,000 deaths annually, or roughly 480 deaths per day, equivalent to one death every three minutes. Thus, the rising incidence of cancer and heart disease is fueling the growth of the medical isotope market.
Leading companies in the medical isotope market are increasingly focusing on strategic collaborations to enhance their competitive positioning. A strategic collaboration is a formal agreement between two or more parties to jointly pursue specific, mutually beneficial objectives. For example, in September 2023, International Isotopes Inc., a U.S.-based medical technology company, partnered with Phantech Medical, a U.S.-based biomedical hardware company, to integrate their solutions for customers. This partnership aims to transform the calibration and reference sources market for pre-clinical imaging by developing, producing, and distributing innovative sealed sources tailored for the medical imaging and theranostics sectors.
In April 2024, Telix Pharmaceuticals Limited, an Australia-based biopharmaceutical company, acquired ARTMS Inc. for an undisclosed sum. This acquisition equips Telix with enhanced access to ARTMS' innovative radiopharmaceutical production technologies, fortifying its position in the development and commercialization of targeted radiopharmaceuticals for cancer imaging and therapy. ARTMS Inc., headquartered in Canada, specializes in the development of technology that revolutionizes the production of diagnostic imaging isotopes.
Major companies operating in the medical isotopes market are Rosatom State Atomic Energy Corporation, Bayer AG, Siemens Healthineers AG, GE HealthCare, Urenco Ltd., Lantheus Holdings Inc., Curium Pharma, Canadian Nuclear Laboratories, Eckert & Ziegler Strahlen- und Medizintechnik AG., Advanced Accelerator Applications a Novartis company, Nordion Inc., NTP Radioisotopes SOC Ltd., The Institute for Radioelements (IRE), NorthStar Medical Radioisotopes LLC, Isotopen Technologien Munchen AG (ITM), EczacIbasI-Monrol Nuclear Products Co., SHINE Medical Technologies LLC, Blue Earth Diagnostics Limited, Isologic Innovative Radiopharmaceuticals, IBA Radiopharma Solutions, Izotop, Coqui RadioPharmaceuticals Corp., Jubilant DraxImage Inc., Positron Corporation
North America was the largest region in the medical isotopes market in 2024. The regions covered in the medical isotopes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the medical isotopes market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The medical isotopes market consists of sales of technetium-99m, carbon-11, and gallium-68 which serve specific purposes in medical diagnosis and therapy. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Medical Isotopes Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on medical isotopes market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for medical isotopes ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The medical isotopes market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Product Type: Stable Isotopes; Radio Isotopes
2) By Production Method: Neutron Activation; Cyclotron; Nuclear Reactor; Other Production Method
3) By Application: Nuclear Therapy; Equipment Radioactive Source; Diagnosis
4) By End Use: Hospitals; Diagnostic Centers; Research Institutes
Subsegments:
1) By Stable Isotopes: Carbon-13; Nitrogen-15; Oxygen-18; Other Stable Isotopes
2) By Radio Isotopes: Technetium-99m; Iodine-131; Cobalt-60; Strontium-89; Other Radio Isotopes
Companies Mentioned: Rosatom State Atomic Energy Corporation; Bayer AG; Siemens Healthineers AG; GE HealthCare; Urenco Ltd.
